January 2004 - Volume 14 - Issue 1 - Contributor Index

View All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Other
Actions
View
Show
Previous of 1 Next
Author Name Article
Ballantyne, Christie M

Effects of PPARα, γ and δ haplotypes on plasma levels of lipids, severity and progression of coronary atherosclerosis and response to statin therapy in the lipoprotein coronary...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Brockmöller, Jürgen

Effects of CYP2C9 polymorphisms on the pharmacokinetics of R- and S-phenprocoumon in healthy volunteers

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Buckland, Paul R

Promoter polymorphisms in glutathione-S-transferase genes affect transcription

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Carter, Waleetka

Human glutathione S-transferase A2 polymorphisms: variant expression, distribution in prostate cancer cases/controls and a novel form

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Chen, Suetnee

Effects of PPARα, γ and δ haplotypes on plasma levels of lipids, severity and progression of coronary atherosclerosis and response to statin therapy in the lipoprotein coronary...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Coleman, Sharon

Promoter polymorphisms in glutathione-S-transferase genes affect transcription

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Coles, Brian

Human glutathione S-transferase A2 polymorphisms: variant expression, distribution in prostate cancer cases/controls and a novel form

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
de Boer, Anthonius

Pharmacoeconomic evaluation of testing for angiotensin-converting enzyme genotype before starting β-hydroxy-β-methylglutaryl coenzyme A reductase inhibitor therapy in men

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
De Smet, Peter AGM

The risk of overanticoagulation in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Gleiter, Christoph H

Effects of CYP2C9 polymorphisms on the pharmacokinetics of R- and S-phenprocoumon in healthy volunteers

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Gotto Jr, Antonio M

Effects of PPARα, γ and δ haplotypes on plasma levels of lipids, severity and progression of coronary atherosclerosis and response to statin therapy in the lipoprotein coronary...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Guy, Carol A

Promoter polymorphisms in glutathione-S-transferase genes affect transcription

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Hoffman, Susan MG

Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Hofman, Albert

The risk of overanticoagulation in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions

Pharmacoeconomic evaluation of testing for angiotensin-converting enzyme genotype before starting β-hydroxy-β-methylglutaryl coenzyme A reductase inhibitor therapy in men

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Hoogendoorn, Bastiaan

Promoter polymorphisms in glutathione-S-transferase genes affect transcription

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Kadlubar, Fred F

Human glutathione S-transferase A2 polymorphisms: variant expression, distribution in prostate cancer cases/controls and a novel form

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Kahlich, Rainer

Effects of CYP2C9 polymorphisms on the pharmacokinetics of R- and S-phenprocoumon in healthy volunteers

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Kammerer, Bernd

Effects of CYP2C9 polymorphisms on the pharmacokinetics of R- and S-phenprocoumon in healthy volunteers

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Kasbergen, A A Harrie

The risk of overanticoagulation in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Kastelein, John JP

Pharmacoeconomic evaluation of testing for angiotensin-converting enzyme genotype before starting β-hydroxy-β-methylglutaryl coenzyme A reductase inhibitor therapy in men

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Kirchheiner, Julia

Effects of CYP2C9 polymorphisms on the pharmacokinetics of R- and S-phenprocoumon in healthy volunteers

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Klungel, Olaf H

Pharmacoeconomic evaluation of testing for angiotensin-converting enzyme genotype before starting β-hydroxy-β-methylglutaryl coenzyme A reductase inhibitor therapy in men

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Leufkens, Hubertus GM

Pharmacoeconomic evaluation of testing for angiotensin-converting enzyme genotype before starting β-hydroxy-β-methylglutaryl coenzyme A reductase inhibitor therapy in men

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Maitland-van der Zee, Anke Hilse

Pharmacoeconomic evaluation of testing for angiotensin-converting enzyme genotype before starting β-hydroxy-β-methylglutaryl coenzyme A reductase inhibitor therapy in men

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Maltais, Lois J

Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Marian, A J

Effects of PPARα, γ and δ haplotypes on plasma levels of lipids, severity and progression of coronary atherosclerosis and response to statin therapy in the lipoprotein coronary...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Meisel, Christian

Effects of CYP2C9 polymorphisms on the pharmacokinetics of R- and S-phenprocoumon in healthy volunteers

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Morel, Fabrice

Human glutathione S-transferase A2 polymorphisms: variant expression, distribution in prostate cancer cases/controls and a novel form

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Nebert, Daniel W

Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Nelson, David R

Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Ning, Baitang

Human glutathione S-transferase A2 polymorphisms: variant expression, distribution in prostate cancer cases/controls and a novel form

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Nowell, Susan

Human glutathione S-transferase A2 polymorphisms: variant expression, distribution in prostate cancer cases/controls and a novel form

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
O'Donovan, Michael C

Promoter polymorphisms in glutathione-S-transferase genes affect transcription

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Rane, Anders

Effects of CYP2C9 polymorphisms on the pharmacokinetics of R- and S-phenprocoumon in healthy volunteers

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Ratnasinghe, D Luke

Human glutathione S-transferase A2 polymorphisms: variant expression, distribution in prostate cancer cases/controls and a novel form

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Roots, Ivar

Effects of CYP2C9 polymorphisms on the pharmacokinetics of R- and S-phenprocoumon in healthy volunteers

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Schwab, Matthias

Effects of CYP2C9 polymorphisms on the pharmacokinetics of R- and S-phenprocoumon in healthy volunteers

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Smith, S Kaye

Promoter polymorphisms in glutathione-S-transferase genes affect transcription

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Stricker, Bruno HCh

The risk of overanticoagulation in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions

Pharmacoeconomic evaluation of testing for angiotensin-converting enzyme genotype before starting β-hydroxy-β-methylglutaryl coenzyme A reductase inhibitor therapy in men

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Tsybouleva, Natalia

Effects of PPARα, γ and δ haplotypes on plasma levels of lipids, severity and progression of coronary atherosclerosis and response to statin therapy in the lipoprotein coronary...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Ufer, Mike

Effects of CYP2C9 polymorphisms on the pharmacokinetics of R- and S-phenprocoumon in healthy volunteers

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
van Duijn, Cornelia M

The risk of overanticoagulation in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions

Pharmacoeconomic evaluation of testing for angiotensin-converting enzyme genotype before starting β-hydroxy-β-methylglutaryl coenzyme A reductase inhibitor therapy in men

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
van Schaik, Ron HN

The risk of overanticoagulation in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
van Vliet, Martin

The risk of overanticoagulation in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Veenstra, David L

Pharmacoeconomic evaluation of testing for angiotensin-converting enzyme genotype before starting β-hydroxy-β-methylglutaryl coenzyme A reductase inhibitor therapy in men

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Visser, Loes E

The risk of overanticoagulation in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Vulto, Arnold G

The risk of overanticoagulation in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Wain, Hester M

Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Walter, Ev-Charlotte

Effects of CYP2C9 polymorphisms on the pharmacokinetics of R- and S-phenprocoumon in healthy volunteers

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Wang, Charles

Human glutathione S-transferase A2 polymorphisms: variant expression, distribution in prostate cancer cases/controls and a novel form

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Witteman, Jacqueline CM

Pharmacoeconomic evaluation of testing for angiotensin-converting enzyme genotype before starting β-hydroxy-β-methylglutaryl coenzyme A reductase inhibitor therapy in men

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Zeldin, Darryl C

Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Actions
View
Show
Previous of 1 Next